Subtopic Deep Dive
Genomic Analysis of Canine Tumors
Research Guide
What is Genomic Analysis of Canine Tumors?
Genomic Analysis of Canine Tumors applies next-generation sequencing and proteomics to identify driver mutations in canine cancers such as osteosarcoma and mast cell tumors.
Researchers use NGS to detect mutations like KIT exon 11 alterations in 26.2% of canine mast cell tumors (Letard et al., 2008, 180 citations) and BRAF mutations in various canine cancers (Mochizuki et al., 2015, 167 citations). Comparative genomics reveals breed-specific predispositions, with pedigree dogs showing elevated risks for certain cancers (Dobson, 2013, 324 citations). Over 10 papers from 2008-2016, cited 150-428 times, establish dogs as models for human oncology.
Why It Matters
Genomic analysis identifies conserved mutations like KIT and BRAF between canine and human tumors, enabling cross-species drug targeting (Letard et al., 2008; Mochizuki et al., 2015). Canine osteosarcoma, occurring 10 times more frequently than in humans, informs pediatric oncology treatments (Fenger et al., 2014, 242 citations). Breed predispositions guide genetic screening and precision medicine in veterinary practice (Dobson, 2013). Comparative pathway analysis of mammary tumors supports shared therapeutic strategies (Uva et al., 2009, 190 citations).
Key Research Challenges
Breed-Specific Mutation Variability
Pedigree dogs show breed-predisposed cancer risks, complicating genomic driver identification across populations (Dobson, 2013, 324 citations). Intrabreed homogeneity aids mapping but limits generalizability (Shearin and Ostrander, 2010, 186 citations). Standardizing NGS across breeds remains difficult.
Translating Mutations to Therapy
KIT gain-of-function mutations occur in 26.2% of mast cell tumors, but targeted therapies lag behind human equivalents (Letard et al., 2008, 180 citations). BRAF mutations demand cross-species validation for inhibitors (Mochizuki et al., 2015, 167 citations). Clinical trial designs face species-specific pharmacokinetic hurdles.
Comparative Genomics Alignment
Aligning canine and human mammary tumor pathways reveals overlaps but inconsistent expression profiles (Uva et al., 2009, 190 citations). Osteosarcoma models require integrating canine frequency data with human pediatric cases (Fenger et al., 2014, 242 citations). Orthologous gene annotation challenges persist.
Essential Papers
Comparative oncology: what dogs and other species can teach us about humans with cancer
Joshua D. Schiffman, Matthew Breen · 2015 · Philosophical Transactions of the Royal Society B Biological Sciences · 428 citations
Over 1.66 million humans (approx. 500/100 000 population rate) and over 4.2 million dogs (approx. 5300/100 000 population rate) are diagnosed with cancer annually in the USA. The interdisciplinary ...
Breed-Predispositions to Cancer in Pedigree Dogs
Jane Dobson · 2013 · ISRN Veterinary Science · 324 citations
Cancer is a common problem in dogs and although all breeds of dog and crossbred dogs may be affected, it is notable that some breeds of pedigree dogs appear to be at increased risk of certain types...
Complex disease and phenotype mapping in the domestic dog
Jessica J. Hayward, Marta G. Castelhano, Kyle C. Oliveira et al. · 2016 · Nature Communications · 273 citations
Rapid evolutionary response to a transmissible cancer in Tasmanian devils
Brendan Epstein, Menna E. Jones, Rodrigo Hamede et al. · 2016 · Nature Communications · 272 citations
Abstract Although cancer rarely acts as an infectious disease, a recently emerged transmissible cancer in Tasmanian devils ( Sarcophilus harrisii ) is virtually 100% fatal. Devil facial tumour dise...
Canine Osteosarcoma: A Naturally Occurring Disease to Inform Pediatric Oncology
Joelle M. Fenger, Cheryl A. London, William C. Kisseberth · 2014 · ILAR Journal · 242 citations
Osteosarcoma (OSA) is the most common form of malignant bone cancer in children and dogs, although the disease occurs in dogs approximately 10 times more frequently than in people. Multidrug chemot...
Dogs as a Model for Cancer
Heather L. Gardner, Joelle M. Fenger, Cheryl A. London · 2015 · Annual Review of Animal Biosciences · 204 citations
Spontaneous cancers in client-owned dogs closely recapitulate their human counterparts with respect to clinical presentation, histological features, molecular profiles, and response and resistance ...
Comparative expression pathway analysis of human and canine mammary tumors
Paolo Uva, Luigi Aurisicchio, James Watters et al. · 2009 · BMC Genomics · 190 citations
Reading Guide
Foundational Papers
Start with Dobson (2013, 324 citations) for breed cancer risks; Letard et al. (2008, 180 citations) for KIT mutations in 191 mast cell tumors; Fenger et al. (2014, 242 citations) for osteosarcoma as pediatric model.
Recent Advances
Mochizuki et al. (2015, 167 citations) on BRAF mutations; Schiffman and Breen (2015, 428 citations) for comparative oncology; Hayward et al. (2016, 273 citations) for phenotype mapping.
Core Methods
NGS for mutation sequencing (exon 11 KIT, BRAF); RT-PCR validation; comparative expression pathway analysis; breed-based genome-wide association studies.
How PapersFlow Helps You Research Genomic Analysis of Canine Tumors
Discover & Search
Research Agent uses searchPapers and exaSearch to find KIT and BRAF mutation papers, then citationGraph on Mochizuki et al. (2015) reveals 167-cited connections to Schiffman and Breen (2015). findSimilarPapers expands to breed predisposition studies like Dobson (2013).
Analyze & Verify
Analysis Agent applies readPaperContent to extract mutation frequencies from Letard et al. (2008), then runPythonAnalysis with pandas to compare KIT exon 11 rates across 191 dogs versus human datasets. verifyResponse (CoVe) and GRADE grading confirm claims like 26.2% prevalence with statistical verification.
Synthesize & Write
Synthesis Agent detects gaps in canine-human BRAF translation from Mochizuki et al. (2015), flags contradictions in breed risks (Dobson, 2013). Writing Agent uses latexEditText, latexSyncCitations for osteosarcoma review, and latexCompile for publication-ready manuscripts with exportMermaid for mutation pathway diagrams.
Use Cases
"Analyze KIT mutation frequencies in canine mast cell tumors across breeds"
Research Agent → searchPapers('KIT mutations canine mast cell') → Analysis Agent → readPaperContent(Letard 2008) → runPythonAnalysis(pandas frequency table from 191 dogs) → CSV export of 26.2% exon 11 rates by breed.
"Write LaTeX review on comparative genomics of canine osteosarcoma"
Research Agent → citationGraph(Fenger 2014) → Synthesis → gap detection → Writing Agent → latexEditText(structured review) → latexSyncCitations(Schiffman 2015, Dobson 2013) → latexCompile(PDF with figures).
"Find code for canine tumor NGS analysis pipelines"
Research Agent → paperExtractUrls(Breen papers) → Code Discovery → paperFindGithubRepo → githubRepoInspect(NGS variant calling scripts) → runPythonAnalysis(test on osteosarcoma datasets).
Automated Workflows
Deep Research workflow scans 50+ papers on canine tumors via searchPapers, producing structured reports with GRADE-scored mutation evidence from Letard et al. (2008) and Mochizuki et al. (2015). DeepScan applies 7-step CoVe analysis to verify breed predispositions in Dobson (2013), checkpointing genomic alignments. Theorizer generates hypotheses on KIT-BRAF co-mutations from citationGraph.
Frequently Asked Questions
What is Genomic Analysis of Canine Tumors?
It uses NGS and proteomics to identify driver mutations like KIT exon 11 in mast cell tumors (26.2% frequency; Letard et al., 2008) and BRAF in various cancers (Mochizuki et al., 2015).
What methods are used?
Next-generation sequencing detects mutations; comparative pathway analysis aligns canine-human profiles (Uva et al., 2009); breed mapping leverages intrabreed homogeneity (Shearin and Ostrander, 2010).
What are key papers?
Dobson (2013, 324 citations) on breed predispositions; Fenger et al. (2014, 242 citations) on osteosarcoma; Letard et al. (2008, 180 citations) on KIT mutations.
What open problems exist?
Translating mutations to therapies; standardizing NGS across breeds; resolving orthologous gene inconsistencies in comparative models.
Research Veterinary Oncology Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Genomic Analysis of Canine Tumors with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Veterinary Oncology Research Research Guide